After a six-week trial, a jury found former pharmaceutical executive Martin Shkreli guilty of three of eight counts related to a scheme in which prosecutors said he defrauded investors into two hedge funds and paid them back by pilfering another company he formed.
The jury of seven women and five men, who deliberated for five days and handed up their verdict after 2 p.m. on Aug. 4 found Shkreli guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]